Microvesicles in active lupus nephritis show Toll‐like receptor 9‐dependent co‐expression of galectin‐3 binding protein and double‐stranded DNA. (25th January 2021)

• Record Type: Journal Article
• Authors: Rasmussen, N. S.; Nielsen, C. T.; Nielsen, C. H.; Jacobsen, S.
• Is Part Of: Clinical and experimental immunology. Volume 204:Number 1(2021)
• Page Start: 64
• Page End: 77
• Publication Date: 2021-01-25
• Subjects: G3BP -- microvesicles -- PBMCs -- SLE -- TLR‐9; Immunopathology -- Periodicals; 616.079
• DOI: 10.1111/cei.13569
• Languages: English
• ISSNs: 0009-9104

Abstract

Summary: Circulating microvesicles (MVs) from patients with systemic lupus erythematosus (SLE) express the type 1 interferon (IFN)‐inducible protein galectin‐3 binding protein (G3BP), which may enhance their deposition in the glomerular basement membrane. The release of G3BP‐expressing MVs from normal peripheral blood mononuclear cells (PBMCs) is induced by Toll‐like receptor 9 (TLR‐9) ligands, and these vesicles contain autoantibody‐accessible double‐stranded DNA (dsDNA). This study compares the release of MVs expressing G3BP and dsDNA from PBMCs derived from SLE patients with or without active lupus nephritis (LN) and from healthy donors, and taps further into the potential dependency on IFN‐α for their generation and impacts of TLR‐7/TLR‐9 co‐stimulation. PBMCs from 10 healthy donors and 12 SLE patients, six of whom had active LN at study inclusion, were stimulated in‐vitro with recombinant human IFN‐α and the TLR‐9 agonists oligodeoxynucleotide (ODN)2216 or ODN2395 alone or in combination with the TLR‐7 agonist gardiquimod. MVs in the supernatants were subsequently isolated by differential centrifugation and their expression of G3BP and dsDNA was quantified by flow cytometry. Stimulation with ODN2395 significantly increased the release of MVs co‐expressing G3BP and dsDNA from PBMCs isolated from healthy donors and SLE patients. The expression of G3BP on individual MVs and the proportion of G3BP and dsDNA double‐positive MVs released were increased in active LN patients. Neither co‐stimulation with gardiquimod nor with the IFN‐α inhibitor IN‐1 had any effect on the MV release induced by ODN2395. In conclusion, the TLR‐9‐mediated inducibility of MVs co‐expressing G3BP and dsDNA is increased in SLE patients with active LN. Abstract : Toll‐like receptor‐9 ligation induces the release of microvesicles (MVs) embroidered with the type 1 interferon‐inducible protein galectin‐3 binding protein (G3BP) and double‐stranded DNA that may become targeted with anti‐DNA autoantibodies. Deposition of such MVs in kidney glomeruli expressing G3BP ligands, may cause lupus nephritis.